The Newly Developed CRF1-Receptor Antagonists, NGD 98-2 and NGD 9002, Suppress Acute Stress-Induced Stimulation of Colonic Motor Function and Visceral Hypersensitivity in Rats
Open Access
- 6 September 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (9) , e73749
Abstract
Corticotropin releasing factor receptor 1 (CRF1) is the key receptor that mediates stress-related body responses. However to date there are no CRF1 antagonists that have shown clinical efficacy in stress-related diseases. We investigated the inhibitory effects of a new generation, topology 2 selective CRF1 antagonists, NGD 98-2 and NGD 9002 on exogenous and endogenous CRF-induced stimulation of colonic function and visceral hypersensitivity to colorectal distension (CRD) in conscious rats. CRF1 antagonists or vehicle were administered orogastrically (og) or subcutaneously (sc) before either intracerebroventricular (icv) or intraperitoneal (ip) injection of CRF (10 µg/kg), exposure to water avoidance stress (WAS, 60 min) or repeated CRD (60 mmHg twice, 10 min on/off at a 30 min interval). Fecal pellet output (FPO), diarrhea and visceromotor responses were monitored. In vehicle (og)-pretreated rats, icv CRF stimulated FPO and induced diarrhea in >50% of rats. NGD 98-2 or NGD 9002 (3, 10 and 30 mg/kg, og) reduced the CRF-induced FPO response with an inhibitory IC50 of 15.7 and 4.3 mg/kg respectively. At the highest dose, og NGD 98-2 or NGD 9002 blocked icv CRF-induced FPO by 67–87% and decreased WAS-induced-FPO by 23–53%. When administered sc, NGD 98-2 or NGD 9002 (30 mg/kg) inhibited icv and ip CRF-induced-FPO. The antagonists also prevented the development of nociceptive hyper-responsivity to repeated CRD. These data demonstrate that topology 2 CRF1 antagonists, NGD 98-2 and NGD 9002, administered orally, prevented icv CRF-induced colonic secretomotor stimulation, reduced acute WAS-induced defecation and blocked the induction of visceral sensitization to repeated CRD.Keywords
This publication has 62 references indexed in Scilit:
- Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: Evidence from animal modelsPharmacology & Therapeutics, 2010
- Corticotropin-releasing factor signaling and visceral response to stressExperimental Biology and Medicine, 2010
- Progress in corticotropin-releasing factor-1 antagonist developmentDrug Discovery Today, 2010
- Cortagine, a CRF1agonist, induces stresslike alterations of colonic function and visceral hypersensitivity in rodents primarily through peripheral pathwaysAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2009
- Visceral Pain: The Neurophysiological Mechanism2009
- Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome?American Journal of Physiology-Gastrointestinal and Liver Physiology, 2009
- Neuroendocrine Control of the Gut During Stress: Corticotropin-Releasing Factor Signaling Pathways in the SpotlightAnnual Review of Physiology, 2009
- From Hans Selye's Discovery of Biological Stress to the Identification of Corticotropin‐ Releasing Factor Signaling PathwaysAnnals of the New York Academy of Sciences, 2008
- Pregabalin decreases visceral pain and prevents spinal neuronal activation in ratsGut, 2007
- Corticotropin-releasing factor receptors and stress-related alterations of gut motor functionJournal of Clinical Investigation, 2007